Logo
x

Search

Subscribe Now

failure

Eli Lilly Reports Results of Jardiance (empagliflozin) in P-III EMPEROR Trial for Heart Failure Patients with Reduced Ejection Fraction with and without Diabetes

Eli Lilly Reports Results of Jardiance (empagliflozin) in P-III EMPEROR Trial for Heart Failure Patients with Reduced Ejection Fra...

  • July 30, 2020
Abbott to Recall Coronary Dilatation Catheters Due to Failure of Balloon Deflation

Abbott to Recall Coronary Dilatation Catheters Due to Failure of Balloon Deflation

  • February 20, 2020
Smith Medical Recalls Medfusion 4000 Syringe Pump Due to its Software Failure

Smith Medical Recalls Medfusion 4000 Syringe Pump Due to its Software Failure

  • December 20, 2019
Abbott Commences New Clinical Trial to Enhance Patient Outcomes in Advanced Heart Failure

    Abbott Commences New Clinical Trial to Enhance Patient Outcomes in Advanced Heart Failure

    • October 25, 2024
    Astellas Reports the US FDA Listing of DIGITIVA to Manage Heart Failure

      Astellas Reports the US FDA Listing of DIGITIVA to Manage Heart Failure

      • September 19, 2024
      Elixir Medical Highlights the Data from INFINITY-SWEDEHEART Study of DynamX Coronary Bioadaptor System for Coronary Artery Disease at ESC 2024

        Elixir Medical Highlights the Data from INFINITY-SWEDEHEART Study of DynamX Coronary Bioadaptor System for Coronary Artery Disease...

        • September 3, 2024
        Diality Reports the US FDA’s Clearance of its Moda-flx Hemodialysis System

          Diality Reports the US FDA’s Clearance of its Moda-flx Hemodialysis System

          • August 6, 2024
          Bayer Reports the P-III (FINEARTS-HF) Study Data of Finerenone to Prevent Heart Failure with Preserved Ejection Fraction

            Bayer Reports the P-III (FINEARTS-HF) Study Data of Finerenone to Prevent Heart Failure with Preserved Ejection Fraction

            • August 5, 2024
            Eli Lilly Reports the P-III (SUMMIT) Trial Data of Tirzepatide to Treat Heart Failure with Preserved Ejection Fraction and Obesity

              Eli Lilly Reports the P-III (SUMMIT) Trial Data of Tirzepatide to Treat Heart Failure with Preserved Ejection Fraction and Obesity

              • August 2, 2024
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.